A collection of Best Stock Ideas recommended by Experts collected from various sources for your benefit to maximise your earnings. For my Personal Recommendations with Detailed Analysis Visit http://http://equityadvise.blogspot.com

Showing posts with label P. Show all posts
Showing posts with label P. Show all posts

Monday, January 12, 2009

Buy Petronet LNG, target of Rs 63: Karvy

Karvy Stock Broking has maintained its buy rating on Petronet LNG Ltd with a target of Rs 63 in its January 12, 2009 research report. "For FY09, we expect the revenue growth of 9.8% to Rs 71,948 million and adjusted profit to rise by 11.9% to Rs 5,309 million. We maintain our Buy rating with target price of Rs 63," says Karvy Stock Broking's research report.
Visit http://equityadvise.blogspot.com for Detailed indepth Stock Analysis by Me.
The blogger is not responsible for any loss arising on account of transactions done on the basis of recommendations/opinions published here. You are advised to consult your Advisor before taking any decision.

Buy Pennar Industries, target of Rs 33: Karvy

Karvy Stock Broking has upgraded its rating on Pennar Industries from market performer to buy with a target of Rs 33 in its January 12, 2009 research report. "For Q3FY09, we expect Pennar Industries Ltd (PIL) to report net sales growth of 11% (YoY) and de growth of 7% (QoQ) to Rs 1598 million. We expect net profit to be around Rs 87.5 million, 13% lower (YoY) and 3% lower (QoQ)."

"We maintain our sales and earning estimates of PIL for FY09 and FY10. Based on earnings, we value PIL at Rs 30 per share (8x of FY10 EPS). To add to that, value from real estate holding, is estimated to be around Rs 3 per share. Hence we retain our target price of PIL at Rs 33 and upgrade our rating from Market performer to BUY due to recent fall in stock price. Currently, PIL is trading at EBITDA multiple of 6xFY09. Our target price also reflects an EBITDA multiple of 6x on FY10," says Karvy Stock Broking's research report.
Visit http://equityadvise.blogspot.com for Detailed indepth Stock Analysis by Me.
The blogger is not responsible for any loss arising on account of transactions done on the basis of recommendations/opinions published here. You are advised to consult your Advisor before taking any decision.

Monday, December 29, 2008

PIRAMAL HEALTHCARE

PIRAMAL HEALTHCARE LTD
BSE: 500302 | NSE: PIRHEALTH | ISIN: INE140A01024 |FV 2.00

Piramal Healthcare is among the leading producers of halothane and isoflurane. With its latest acquistion of Minrad Internation (a generic inhalation anaesthetics company), Piramal Healthcare is set to strengthen its global presence in the critical care space, as the deal will give Piramal immediate access into the US market for the country's largest selling inhalation anaethetic sevaflurane.
Piramal has been on the prowl for quite sometime with its acquisition of Rhodia's Inhalation Anaesthetics business in 2004 and 'Haemaccel' brand acquisition from PlasmaSelectAG of Germany.


RECOMMENDATIONS :
With the continued favourable environment for CRAMS business due to its inherent cost advantages, and strong MNC relations, Piramal will continue to be a big beneficiary of increased outsourcing from India. Its domestic business too continues to be strong and steady.
The Company should outperform its peers comfortably and can be considered for accumulation at every declines.


Other Brokerages Targets :
Angel Broking has maintained its Buy rating on Piramal Healthcare with a target price of Rs 340.
Kotak Securities has maintained its Accumulate rating on Piramal Healthcare with a target price of Rs 313.
Sharekhan has maintained its buy rating on Piramal Healthcare with a target of Rs 434 in its December 23, 2008 research report.
SBICAP Securities
has maintained its buy rating on Piramal Healthcare with a target of Rs 360.
Motilal Oswal has maintained its buy rating on Piramal Healthcare.
Religare research has maintained buy rating on Piramal Healthcare with target price of Rs 412.

Also visit my other blogs namely
http://goodfundadvisor.blogspot.com/
http://goodtravelplanner.blogspot.com/
http://indiahotelstariff.blogspot.com/

Monday, December 22, 2008

Proctor & Gamble - No Gamble pure Logical Investment

Underpenetrated markets, low per capita consumption and well established brands will translate into high growth rates for Procter & Gamble.




A basket of popular products, access to superior technology and good understanding of consumer needs are factors that have helped Procter & Gamble Hygiene and Health Care (P&G) report robust growth rates in the past. The company, however, has not been resting on its laurels. In fact, P&G has been proactive in building near-term as well as long-term growth drivers, which will not only help maintain leadership in its businesses, but also in sustaining growth rates going ahead. In this light as well as given the current uncertain market conditions, this stock is a good investment, offering a combination of growth as well as safety at reasonable valuations.

Strong businesses
For decades, its ‘Vicks’ brand has been synonymous with remedies that cure cold and cough. Various innovations in the past have helped maintain healthy sales growth in the healthcare business (Vicks branded products; estimated market share of 17 per cent), which contributed a little over Rs 300 crore to sales in FY08. Going forward, says Pritee Panchal, analyst, SBICAP Securities, “There is a lot of potential in this segment, but don’t expect high growth rates-expect about 10 per cent annual growth on an average. That’s because, Vicks Vaporub, Formula 44 and Inhaler are seasonal products. Vicks Cough Drops (in candy form) though is more of confectionary product and will help this segment grow fast.”

The feminine care business, which sells sanitary napkins under the ‘Whisper’ brand, has reported an average annual growth rate of 20 per cent in the last five years. It clocked sales of Rs 340 crore in FY08, representing a year-on-year growth of 21 per cent. The growth rate was higher at almost 30 per cent in the first quarter ended September 2008, driven by 50 per cent growth in ‘Whisper Choice’ and 34 per cent in ‘Whisper Ultra’. Says Panchal, “A 50 per cent growth in the mass segment product (Whisper Choice) in Q1FY09 signifies growing acceptance, affordability and usage of these products among the middle-class urban women.”

Analysts expect this business to clock growth rates of over 22 per cent (average), which should help Whisper, a leader in urban India with a market share of 50 per cent (value terms), become a $100 million brand in two years.

Favourable prospects
While the slowing economic growth may have a marginal influence on demand, the fact that the company’s products are driven more by necessity rather than luxury (discretionary) provides comfort. Notably, the overall growth dynamics for the businesses continue to be very favourable.

Consider this. In case of sanitary napkins, statistics (source: company) indicate that there are 26.6 crore menstruating women in India, of which, only three per cent use branded sanitary napkins. Even if the economically weaker population is excluded, the penetration levels would be far lower than 32-60 per cent in other developing economies like Thailand, Philippines and China (in developed countries like USA and Japan, it is over 85 per cent). The other evidence of long-term growth opportunity is the fact that by 2050, more than half of India’s population will be under the age of 25 years.

That apart, the growing population of working women, increasing literacy levels, higher disposable incomes and the expanding middle- and upper-middle class are some key factors that clearly indicate the huge potential for companies like P&G and hence, will help drive growth rates in the future.

Right moves
Among various initiatives, the introduction of low value packs (Rs 5 pack of Vicks Vaporub) and mass segment products (Whisper Choice) has helped the businesses grow at a fast clip on the back of increased volumes. On the other hand, the company’s emphasis on delivering new solutions based on customer needs has helped it stay ahead of competition. For instance, in FY08, P&G upgraded its ‘Whisper Maxi’ product in line with customer needs.

In the long-run, P&G’s initiative through the ‘Whisper School Program’ will help raise awareness among consumers and build the path for future growth. The programme involves educating adolescent girls and mothers about hygiene care, and so far has reached 6 million girls (1.6 million in FY08). The impact of this programme has been encouraging. According to the studies undertaken, while two-thirds of the school girls were using cloth (instead of sanitary napkin) before the programme, only six per cent continued to use cloth after the programme.

ROBUST MARGINS
Rs crore FY08 FY09E FY10E
Net sales 646 775 910
Net profit 131 170 200
OPM (%) 28 28 28
EPS (Rs) 40.5 52 62
PE (x) 18.2 14 11.9
Source: CapitaLine Plus, analysts reports

In a recent move, the company tied up with National Rural Health Mission, Rajasthan, to educate the rural women about hygiene issues. Such measures should help improve education levels among women and thus, increase penetration of sanitary napkins in the rural areas, which so far has been negligible. In short, it should prove helpful for P&G in the long run.

Growth blocks in place
During FY06-08, the company invested nearly Rs 60 crore towards capacity creation (Rs 10 crore was invested in its Goa plant for hygiene products and Rs 26.7 crore in Baddi plants for healthcare products, in FY08 alone), thereby almost doubling the fixed assets to Rs 123.10 crore in 2007-08. While the two Baddi plants enjoy tax incentives and help the company lower its tax expenses, these investments are sufficient to take care of the company’s capacity requirements for the next few years. Nonetheless, the low capital-intensive nature of the businesses and high cash-flows suggest that internal accruals are more than enough to take care of future capex, whenever the need arises.

More importantly, the company enjoys the backing of its US-based parent, The Procter and Gamble Company, which offers the necessary technology and products, helping it to sustain growth rates. In return, the company pays royalty to its parent, which works out to about five per cent of sales. Even thereafter, P&G ends up with a hefty net profit margin of 20 per cent (partly helped by tax incentives), which is enviable.

Investment rationale
There is no doubt that the company has in place the key growth ingredients like strong brands, access to latest technology, healthy balance-sheet and an insight into consumer behaviour. The under penetrated markets, rising population of working women, low per capita consumption and, improving income and literacy levels are also conducive for long-term growth.

All these should help P&G achieve topline growth of 16-18 per cent for many years and become a Rs 1,000 crore company in the next three years. Notably, profits should grow faster at over 18 per cent, to some extent helped by lower taxes. At Rs 735, quoting at a PE of 14 times (not adjusting for the cash, worth Rs 51 per share, held as on June 2008), the stock can deliver 18-20 per cent annual returns for next two-three years.



Also visit my other blogs namely
http://goodfundadvisor.blogspot.com/
http://goodtravelplanner.blogspot.com/
http://indiahotelstariff.blogspot.com/

Sunday, December 21, 2008

PVR - BUY

Investors with a two-year horizon can consider buying the shares of PVR, a player in the multiplex movie exhibition space, considering its good business prospects and relatively better positioning among peers.

At Rs 85, the stock trades at eight times its likely 2008-09 per share earnings. This is at a discount to the multiple that Inox Leisure enjoys, despite PVR having a bigger scale of operation in terms of the number of screens operated and better profit margins (over eight per cent), the highest among listed movie exhibition players.


Improving average ticket price, strength in food and beverages sales and continuing strength in garnering advertising revenues are key positives for PVR.

Other positives are increasing spend per head of visitors, improving contribution of revenues from its screens to movies leading to a higher share for PVR and profits to be booked from runaway hit Jaane Tu Ya Jaane Na, which its subsidiary co-produced.

A decline in occupancy levels, largely due to lower footfalls on the back of terror attacks and threats, and a slowdown in the real-estate market, forcing developers to decrease pace of development in malls and multiplexes, are areas of concern.

PVR has 101 screens across 25 locations in 14 cities in the country. Its performance in 2005-08 has been impressive with revenues growing at a compounded annual rate of 57.3 per cent to Rs 265.9 crore and profits at 79.2 per cent to Rs 21.6 crore. The potential for the film industry and, ipso facto, box-office collections is high for a country such as India, where there is a lack of alternative sources of cheap entertainment.

A recent report of PWC-FICCI on Indian entertainment and media, expects the film industry to grow annually at 13 per cent to Rs 17,550 crore by 2012, while domestic box-office collection is set to grow at 11 per cent to Rs 12,250 crore.

PVR appears well-placed with its dual model of super high-priced tickets in key metros and low-priced ones in tier-I and tier-II cities.
Ticket pricing and other businesses expand

One of the key parameters of cinema screens is the average ticket price level. Ticket sales and revenue share from screens (franchisee developers) operations contribute over 60 per cent of revenues.

PVR has seen its average ticket price (ATP) improve continuously over the last five quarters to Rs 140 currently.

This has been made possible by a hybrid pricing model adopted by the company, depending on the location where it operates. In places such as Saket in Delhi, its ATP is as high as Rs 225. This represents its pricing power on the back of patronage that it enjoys.

The spending per head on other utilities such as food and beverages has also been impressive.

This stands at Rs 39 currently, up 25 per cent over last year. This is a relatively high-margin business, which has increased its contribution to revenues to nearly 21 per cent currently, and is growing by over 30 per cent annually.

Advertising, the other key contributor to revenues (13 per cent) has seen increasing growth rates. From 59 per cent growth in 2008-09, it has improved to over 65 per cent in the first half of this year.

As a more easily accountable form of viewer-ship compared to television or radio, advertisers may be less inclined to cut spends on this medium.

However, concerns may stem from the fact that PVR’s occupancy has declined to 36.5 per cent compared to above 40 per cent levels in 2007.

Footfalls have also declined, on the back of terror threats. However, there is a seasonality associated with movie screens as the December and June quarter are the usually stronger ones. This may also prompt advertisers to tailor budgets accordingly.
Movies and distribution look good

PVR has consistently accounted for over 10 per cent of collections of movie revenues from its screens. In movies such as the hits Jab We Met and Taare Zameen Par this figure went to over 18 per cent.

This movie-screening and distribution has a twin effect for the company. One, it improves revenue share for itself. 0Two, its success and wider reach means that it can pay a lower share to the distributor. In fact, the share paid to distributors has been falling consistently. This, in turn, would improve margins for PVR as it is the chief cost component.

PVR Pictures, a subsidiary, is in the business of producing and distributing films. It has co-produced films such as Taare Zameen Par and , both of which were runaway hits. The latter movie was launched in the second quarter of this fiscal and waits booking of profits.

This division has received a shot in the arm with an investment of Rs 120 crore from JP Morgan and ICICI Venture. PVR Picture hopes to produce 8-10 films over the next year.



Improving average ticket price, strength in food and beverages sales and in garnering advertising revenues are key positives for PVR.




Also visit my other blogs namely
http://goodfundadvisor.blogspot.com/
http://goodtravelplanner.blogspot.com/
http://indiahotelstariff.blogspot.com/